|
CO
|
China Cord Blood Corporation
|
US
|
NYSE
|
|
COCP
|
Cocrystal Pharma, Inc.
|
US
|
NASDAQ
|
|
CRSP
|
CRISPR Therapeutics AG
|
US
|
NASDAQ
|
|
CTKB
|
Cytek Biosciences, Inc.
|
US
|
NASDAQ
|
|
CYAD
|
Celyad SA
|
US
|
NASDAQ
|
|
CYCC
|
Cyclacel Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CYCCP
|
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock
|
US
|
NASDAQ
|
|
CYT
|
Cyteir Therapeutics, Inc.
|
US
|
NASDAQ
|
|
DBTX
|
Decibel Therapeutics, Inc.
|
US
|
NASDAQ
|
|
EDIT
|
Editas Medicine, Inc.
|
US
|
NASDAQ
|
|
EFTR
|
eFFECTOR Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ELOX
|
Eloxx Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ENZ
|
Enzo Biochem, Inc.
|
US
|
NYSE
|
|
EQ
|
Equillium, Inc.
|
US
|
NASDAQ
|
|
EXPO
|
Exponent, Inc.
|
US
|
NASDAQ
|
|
FATE
|
Fate Therapeutics, Inc.
|
US
|
NASDAQ
|
|
FDMT
|
4D Molecular Therapeutics, Inc.
|
US
|
NASDAQ
|
|
FHTX
|
Foghorn Therapeutics Inc.
|
US
|
NASDAQ
|
|
FIXX
|
Homology Medicines, Inc.
|
US
|
NASDAQ
|
|
FREQ
|
Frequency Therapeutics, Inc.
|
US
|
NASDAQ
|